Skip to main content
ToolGen Incorporated logo

ToolGen Incorporated — Investor Relations & Filings

Ticker · 199800 ISIN · KR7199800004 KO Professional, scientific and technical activities
Open in API
Filings indexed 309 across all filing types
Latest filing 2022-03-15 Audit Report / Informat…
Country KR South Korea
Listing KO 199800

About ToolGen Incorporated

http://www.toolgen.com/eng

ToolGen Incorporated is a biotechnology company specializing in the development and application of genome editing technology. Founded in 1999, the company has developed multiple generations of gene editing tools, including Zinc Finger Nucleases (ZFNs), Transcription Activator-Like Effector Nucleases (TALENs), and the CRISPR-Cas9 system. ToolGen is a key patent holder for CRISPR-Cas9 technology, being the first to file a patent for its application in eukaryotic cells. The company's business model focuses on developing therapeutics and agricultural products, as well as monetizing its intellectual property through licensing and collaborations. Its primary mission is to translate genetic knowledge into transformative products for biomedicine and agriculture.

Recent filings

Filing Released Lang Actions
사업보고서 (2021.12)
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report' (감사보고서) for ToolGen, Inc. for the fiscal year ending December 31, 2021. It includes the independent auditor's opinion, financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes. While it contains financial statements, the primary purpose and structure of the document, as indicated by the title and the inclusion of the auditor's opinion, classify it as an Audit Report. FY 2021
2022-03-15 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by ToolGen. It outlines the date, location, and specific agenda items (such as financial statement approval, director/auditor appointments, and remuneration limits) to be voted on by shareholders. This type of document is a standard proxy solicitation and information statement provided to shareholders to inform them of upcoming meeting details and voting items.
2022-03-10 Korean
주주총회집중일개최사유신고
AGM Information Classification · 1% confidence The document is a formal notification filed by ToolGen regarding the scheduling of its Annual General Meeting (AGM) on a 'concentrated date' (a date where many companies hold their AGMs). It explains the operational reasons for choosing March 30th, 2022, despite the KOSDAQ association's guidance. Since this is a regulatory disclosure regarding meeting logistics and does not fit into specific categories like proxy solicitation or voting results, it is classified as a general regulatory filing.
2022-03-10 Korean
주주총회소집공고
AGM Information Classification · 1% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for ToolGen, dated March 10, 2022. It outlines the meeting agenda, including financial statement approval, director appointments, and governance matters. While it contains business information, it is primarily a proxy statement/notice for an upcoming shareholder meeting, which falls under the Proxy Solicitation & Information Statement category.
2022-03-10 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 1% confidence The document is a regulatory filing from a Korean company (ToolGen) announcing a significant change (over 30%) in revenue or profit structure. This is a standard disclosure requirement in the Korean stock market (KRX) for listed companies to report material financial changes before the final audited annual report is finalized. It provides key financial highlights and reasons for the variance, fitting the definition of an Earnings Release (ER) as it serves as an initial announcement of financial performance metrics. FY 2021
2022-03-10 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is explicitly labeled as a '정정신고' (Correction Report). It details changes to the number of stock options granted to employees and directors, including specific tables showing the 'before' and 'after' figures. This type of disclosure regarding stock option grants and their subsequent amendments is a standard regulatory requirement for listed companies in Korea, falling under the category of general regulatory filings that do not fit into specific categories like M&A or dividends.
2021-12-24 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.